Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / October / Are Dolphins the New Alzheimer’s Sentinels?
Neurology Genetics and epigenetics Analytical science Biochemistry and molecular biology

Are Dolphins the New Alzheimer’s Sentinels?

New transcriptomic analysis links neurotoxin buildup in stranded dolphins to altered gene expression and hallmark Alzheimer’s pathology

10/28/2025 News 2 min read

Share

Credit: Dolphin image sourced from Adobe Stock

Researchers have identified molecular signatures of Alzheimer’s disease (AD) in the brains of bottlenose dolphins exposed to harmful algal blooms (HABs) in Florida’s Indian River Lagoon, according to findings published in Communications Biology. The study provides a detailed look at how chronic exposure to algal neurotoxins may influence neurodegenerative processes – insights that could inform future work on environmental contributors to neurological disease.

Over nearly a decade, investigators examined brain tissue from 20 dolphins that had stranded along the Indian River Lagoon between 2010 and 2019. Dolphins stranded during algal bloom seasons (June-November) had markedly higher concentrations of the neurotoxin 2,4-diaminobutyric acid (2,4-DAB) – up to 2,900 times greater than those measured in non-bloom seasons. The toxin, produced by cyanobacteria and other algae, has been linked to excitatory neurotoxicity and impaired GABAergic signaling.

Whole-transcriptome analysis revealed 536 differentially expressed genes in bloom-season dolphins. Many were involved in synaptic transmission, basement membrane integrity, and inflammatory pathways – biological systems that are also disrupted in AD. The study identified decreased expression of genes responsible for glutamate decarboxylase activity, suggesting impaired GABA synthesis, alongside increased expression of genes in the laminin-3 complex, which regulates the blood–brain barrier and neuron-glia interactions.

Several genes associated with AD risk and progression were elevated with 2,4-DAB exposure, including APOE, AGER, and MT-ND1. In some dolphins, APOE expression rose more than sixfold compared with non-bloom counterparts. The researchers also documented increased transcription of APP, MAPT, and TARDBP – genes that encode amyloid precursor protein, tau, and TDP-43, respectively, all central to AD pathology. These molecular patterns were supported by histological findings: amyloid-β plaques, tau tangles, and TDP-43 inclusions were observed in cortical tissue.

Importantly for diagnostic and comparative pathology, the authors note that dolphins naturally develop AD-like lesions with age, positioning them as sentinel species for environmental neurotoxicity. The ability to correlate toxin levels, gene expression, and histopathology in archived dolphin tissue provides a model for studying chronic toxin exposure and neurodegenerative risk in marine and possibly human populations.

While the study does not imply direct causation between algal toxins and Alzheimer’s disease in humans, it underscores the diagnostic value of transcriptomic profiling in environmental neuropathology. As HABs intensify with climate warming, understanding molecular responses in sentinel species could help identify early biomarkers of neurotoxin exposure and guide surveillance of populations at risk for toxin-linked neurological disorders.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.